Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis
Ji‐Seung Yoo, Michihito Sasaki, Steven X. Cho, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 1011
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 98
SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression
Najla Arshad, Maudry Laurent-Rolle, Wesam S. Ahmed, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 120, Iss. 1
Open Access | Times Cited: 86
SARS-CoV-2 biology and host interactions
Silvio Steiner, Annika Kratzel, G. Tuba Barut, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 4, pp. 206-225
Closed Access | Times Cited: 83
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
Vladimir N. Uversky, Elrashdy M. Redwan, William Makis, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 991-991
Open Access | Times Cited: 80
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 68
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection
Fei Gao, Vamsee Mallajosyula, Prabhu S. Arunachalam, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 864-878.e4
Open Access | Times Cited: 59
Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5
Yongfeng Lai, Yuan Gao, Junhong Lin, et al.
Cell Metabolism (2024) Vol. 36, Iss. 4, pp. 822-838.e8
Closed Access | Times Cited: 21
The role of B cells in COVID-19 infection and vaccination
Shiru Chen, Fei Guan, Fabio Candotti, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 64
Immunosenescence and COVID-19
Jacek M. Witkowski, Tamàs Fülöp, Ewa Bryl
Mechanisms of Ageing and Development (2022) Vol. 204, pp. 111672-111672
Open Access | Times Cited: 56
SARS-CoV-2: A Master of Immune Evasion
Alberto Rubio‐Casillas, Elrashdy M. Redwan, Vladimir N. Uversky
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1339-1339
Open Access | Times Cited: 54
Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 51
Revisiting IRF1-mediated antiviral innate immunity
Hao Zhou, Yan‐Dong Tang, Chunfu Zheng
Cytokine & Growth Factor Reviews (2022) Vol. 64, pp. 1-6
Closed Access | Times Cited: 49
Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19
Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, et al.
Clinical Immunology (2022) Vol. 237, pp. 108991-108991
Open Access | Times Cited: 47
Immunosenescence and inflamm-ageing in COVID-19
Mohammad Reza Zinatizadeh, Peyman Kheirandish Zarandi, Mohsen Ghiasi, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101818-101818
Open Access | Times Cited: 40
Defining the role of natural killer cells in COVID-19
Madeline Lee, Catherine A. Blish
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1628-1638
Open Access | Times Cited: 36
Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants
Miyu Moriyama, Carolina Lucas, Valter Silva Monteiro, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 16
Open Access | Times Cited: 30
SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19
Ariana Arduini, Frederique Laprise, Chen Liang
Viruses (2023) Vol. 15, Iss. 4, pp. 871-871
Open Access | Times Cited: 23
The multiple roles of interferon regulatory factor family in health and disease
Luyao Wang, Yanghui Zhu, Nan Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Targeting MHC-I inhibitory pathways for cancer immunotherapy
Jun Wang, Lu Qiao, Xufeng Chen, et al.
Trends in Immunology (2024) Vol. 45, Iss. 3, pp. 177-187
Closed Access | Times Cited: 12
Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses
Jordan A. Hartmann, Marcella R. Cardoso, Maria Cecília Ramiro Talarico, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2393-2410.e14
Open Access | Times Cited: 9
SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions
Smita Vinjamuri, Lenong Li, Marlène Bouvier
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D
Madeline Lee, Michelle Leong, Arjun Rustagi, et al.
Cell Reports (2022) Vol. 41, Iss. 13, pp. 111892-111892
Open Access | Times Cited: 35
Epidemiology and Clinical Presentation of COVID-19 in Older Adults
Yasin Abul, Ciera Leeder, Stefan Gravenstein
Infectious Disease Clinics of North America (2022) Vol. 37, Iss. 1, pp. 1-26
Open Access | Times Cited: 32
SARS-CoV-2 ORF8 reshapes the ER through forming mixed disulfides with ER oxidoreductases
Ping Liu, Xi Wang, Yiwei Sun, et al.
Redox Biology (2022) Vol. 54, pp. 102388-102388
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top